Skip to main content
  • NOBLE Update: CABG Keeps Edge Over PCI in Left Main CAD

    New data cast new light on EXCEL controversy

    More complete data from the NOBLE trial didn't change a preliminary finding that patients with left main coronary artery disease did better after coronary artery bypass grafting (CABG) than stenting at 5 years.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details